Search Orphan Drug Designations and Approvals
-
| Generic Name: | Bioartificial liver system utilizing encapsulated human Hep G2 hepatoblastoma cells in a fluidised bed bioreactor (BAL). |
|---|---|
| Date Designated: | 09/09/2020 |
| Orphan Designation: | Treatment of Acute Liver failure. |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ESPL Regulatory Consulting Limited 25 Bank Place Blackpool Retail Park, Blackpool, Co. Cork Mallow, Cork Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







